Interactions between host epigenetics and microbiota: Who does what to whom, when, and why? - 05/06/23
, Susan V. Lynch, PhD e, f, g, ⁎ 
Key words : Childhood asthma, DNA methylation, maternal immunity, trained immunity, microbiome
Le texte complet de cet article est disponible en PDF.
| Supported by grants R21AI133765 and P01AI148104 (to S.V.L. and D.V.), R21AI144722 (to D.V.), and U19AI125357 (to D.V.). |
|
| Disclosure of potential conflict of interest: D. Vercelli is an inventor in the patents PCT/US2021/016918 (“Therapeutic Fractions and Proteins from Asthma-Protective Farm Dust”), PCT/EP2019/085016 (“Barn Dust Extract for the Prevention and Treatment of Diseases”), and PCT/EP2019/074562 (“Method of Treating and/or Preventing Asthma, Asthma Exacerbations, Allergic Asthma, and/or Associated Conditions with Microbiota Related to Respiratory Disorders”). S. V. Lynch is a board member and consultant for the biotechnology company Siolta Therapeutics, Inc, and holds stock in the company. |
Vol 151 - N° 6
P. 1465-1467 - juin 2023 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
